Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Charles Manning

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Plos One|December 19, 2009
Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPOMichelle Sexton, Grace Woodruff, Eiron Cudaback, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 26, 2010
Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurementsGregory D Ayers, Eliot T McKinley, Ping Zhao, et al.
Translational Oncology|July 12, 2020
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancerAllison S Cohen, Ling Geng, Ping Zhao, et al.
European Journal of Medicinal Chemistry|March 6, 2018
Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([<sup>18</sup>F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammationDewei Tang, Masayuki Fujinaga, Akiko Hatori, et al.
Molecular Imaging and Biology|June 10, 2010
A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidineNing Guo, Jingping Xie, H Charles Manning, et al.
Annals of Nuclear Medicine|April 23, 2015
[(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot studyEliot T McKinley, Jennifer M Watchmaker, A Bapsi Chakravarthy, et al.
Molecular Imaging and Biology|May 15, 2015
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung CancerMohamed Hassanein, Matthew R Hight, Jason R Buck, et al.
Scientific Reports|September 28, 2016
<sup>18</sup>F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing SarcomaChristy L Osgood, Mohammed N Tantawy, Nichole Maloney, et al.
Plos One|October 31, 2015
Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary StudyJason R Buck, Eliot T McKinley, Allie Fu, et al.
Oncotarget|August 20, 2016
Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progressionJingbo Qiao, Magdalena M Grabowska, Ingrid S Forestier-Roman, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Plos One|December 19, 2009
Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPOMichelle Sexton, Grace Woodruff, Eiron Cudaback, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|May 26, 2010
Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurementsGregory D Ayers, Eliot T McKinley, Ping Zhao, et al.
Translational Oncology|July 12, 2020
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancerAllison S Cohen, Ling Geng, Ping Zhao, et al.
European Journal of Medicinal Chemistry|March 6, 2018
Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([<sup>18</sup>F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammationDewei Tang, Masayuki Fujinaga, Akiko Hatori, et al.
Molecular Imaging and Biology|June 10, 2010
A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidineNing Guo, Jingping Xie, H Charles Manning, et al.
Annals of Nuclear Medicine|April 23, 2015
[(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot studyEliot T McKinley, Jennifer M Watchmaker, A Bapsi Chakravarthy, et al.
Molecular Imaging and Biology|May 15, 2015
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung CancerMohamed Hassanein, Matthew R Hight, Jason R Buck, et al.
Scientific Reports|September 28, 2016
<sup>18</sup>F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing SarcomaChristy L Osgood, Mohammed N Tantawy, Nichole Maloney, et al.
Plos One|October 31, 2015
Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary StudyJason R Buck, Eliot T McKinley, Allie Fu, et al.
Oncotarget|August 20, 2016
Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progressionJingbo Qiao, Magdalena M Grabowska, Ingrid S Forestier-Roman, et al.
Pageof 12